FOXRED1 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test
Comprehensive Genetic Testing for Mitochondrial Disorders
The FOXRED1 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with mitochondrial energy production disorders. Mitochondrial complex I deficiency is a serious condition affecting the body’s primary energy production system, leading to significant neurological and metabolic complications.
What This Advanced Genetic Test Measures
This sophisticated NGS-based test specifically analyzes the FOXRED1 gene, which encodes a protein essential for the proper assembly and function of mitochondrial complex I. Complex I is the largest enzyme in the mitochondrial respiratory chain and plays a critical role in cellular energy production through oxidative phosphorylation.
- Comprehensive analysis of the entire FOXRED1 gene sequence
- Detection of point mutations, insertions, and deletions
- Identification of variants affecting protein function
- Assessment of genetic changes impacting mitochondrial energy metabolism
Who Should Consider This Genetic Test
This test is particularly important for individuals presenting with symptoms suggestive of mitochondrial disorders:
- Infants and children with unexplained neurological deterioration
- Patients experiencing progressive muscle weakness and fatigue
- Individuals with developmental delays and regression
- Cases of unexplained metabolic acidosis
- Patients with seizures unresponsive to conventional treatments
- Individuals with family history of mitochondrial disorders
- Cases of Leigh syndrome or similar neurological conditions
Significant Benefits of Early Detection
Early identification of FOXRED1 gene mutations provides numerous advantages for patients and families:
- Accurate diagnosis enabling targeted treatment approaches
- Improved understanding of disease progression and prognosis
- Opportunity for family planning and genetic counseling
- Access to specialized mitochondrial disease management
- Potential enrollment in clinical trials and research studies
- Better coordination of multidisciplinary care
Understanding Your Test Results
Our comprehensive genetic counseling service helps interpret your results with clarity and compassion:
- Positive Result: Indicates the presence of pathogenic variants in the FOXRED1 gene, confirming mitochondrial complex I deficiency diagnosis
- Negative Result: Suggests no detectable mutations in the FOXRED1 gene, though other genetic causes may need investigation
- Variant of Uncertain Significance: Requires further clinical correlation and possibly family studies
- Carrier Status: Important information for family planning and genetic counseling
Test Pricing and Details
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.
Take Control of Your Genetic Health Today
Don’t let uncertainty about mitochondrial disorders affect your quality of life. Our FOXRED1 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test provides the clarity needed for informed medical decisions. With advanced NGS technology and expert genetic counseling, you’ll receive comprehensive insights into your genetic health.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book this essential diagnostic test. Our team is ready to guide you through every step of the testing process and help you understand your results with compassion and expertise.
Remember: Early detection through genetic testing can significantly impact treatment outcomes and quality of life for individuals with mitochondrial disorders. Take the first step toward genetic clarity and personalized medical care.
